Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

WT1 expression in the female genital tract.

Bárcena C, Oliva E.

Adv Anat Pathol. 2011 Nov;18(6):454-65. doi: 10.1097/PAP.0b013e318234aaed.

PMID:
21993272
3.

Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.

Zhao C, Bratthauer GL, Barner R, Vang R.

Am J Surg Pathol. 2007 Sep;31(9):1378-86.

PMID:
17721194
4.

SF-1 is a diagnostically useful immunohistochemical marker and comparable to other sex cord-stromal tumor markers for the differential diagnosis of ovarian sertoli cell tumor.

Zhao C, Barner R, Vinh TN, McManus K, Dabbs D, Vang R.

Int J Gynecol Pathol. 2008 Oct;27(4):507-14. doi: 10.1097/PGP.0b013e31817c1b0a.

PMID:
18753972
5.

Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium.

Egan JA, Ionescu MC, Eapen E, Jones JG, Marshall DS.

Int J Gynecol Pathol. 2004 Apr;23(2):119-22.

PMID:
15084839
6.
7.

Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.

McCluggage WG, Young RH.

Semin Diagn Pathol. 2005 Feb;22(1):3-32. Review.

PMID:
16512597
8.

Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.

Yemelyanova A, Ji H, Shih IeM, Wang TL, Wu LS, Ronnett BM.

Am J Surg Pathol. 2009 Oct;33(10):1504-14. doi: 10.1097/PAS.0b013e3181ac35f5.

PMID:
19623034
9.

WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma.

Al-Hussaini M, Stockman A, Foster H, McCluggage WG.

Histopathology. 2004 Feb;44(2):109-15.

PMID:
14764054
10.

p16 expression in the female genital tract and its value in diagnosis.

O'Neill CJ, McCluggage WG.

Adv Anat Pathol. 2006 Jan;13(1):8-15. Review.

PMID:
16462152
11.

HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.

McCluggage WG, Connolly LE, McBride HA, Kalloger S, Gilks CB.

Histopathology. 2012 Mar;60(4):547-53. doi: 10.1111/j.1365-2559.2011.04105.x. Epub 2012 Jan 17.

PMID:
22250726
12.

Ovarian endometrioid carcinomas simulating sex cord-stromal tumors: a study using inhibin and cytokeratin 7.

Guerrieri C, Frånlund B, Malmström H, Boeryd B.

Int J Gynecol Pathol. 1998 Jul;17(3):266-71.

PMID:
9656124
13.

Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.

Zhao C, Vinh TN, McManus K, Dabbs D, Barner R, Vang R.

Am J Surg Pathol. 2009 Mar;33(3):354-66. doi: 10.1097/PAS.0b013e318188373d.

PMID:
19033865
14.

Wilms' tumor gene 1 (WT1) in endometrial carcinoma.

Coosemans A, Moerman P, Verbist G, Maes W, Neven P, Vergote I, Van Gool SW, Amant F.

Gynecol Oncol. 2008 Dec;111(3):502-8. doi: 10.1016/j.ygyno.2008.08.032. Epub 2008 Oct 16.

PMID:
18929401
15.

The diagnostic utility of inhibin staining in ovarian neoplasms.

Pelkey TJ, Frierson HF Jr, Mills SE, Stoler MH.

Int J Gynecol Pathol. 1998 Apr;17(2):97-105.

PMID:
9553804
16.

Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary.

Rishi M, Howard LN, Bratthauer GL, Tavassoli FA.

Am J Surg Pathol. 1997 May;21(5):583-9.

PMID:
9158684
17.

Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary.

Tornos C, Soslow R, Chen S, Akram M, Hummer AJ, Abu-Rustum N, Norton L, Tan LK.

Am J Surg Pathol. 2005 Nov;29(11):1482-9. Erratum in: Am J Surg Pathol. 2006 Jan;30(1):140.

PMID:
16224215
18.

[Application of immunohistochemistry and its limitations in diagnosis of ovarian sex cord-stromal tumor].

Liu AJ.

Zhonghua Bing Li Xue Za Zhi. 2010 Jan;39(1):62-5. Chinese. No abstract available.

PMID:
20388406
19.
20.

Value of inhibin in the identification of granulosa cell tumors of the ovary.

Hildebrandt RH, Rouse RV, Longacre TA.

Hum Pathol. 1997 Dec;28(12):1387-95.

PMID:
9416696

Supplemental Content

Support Center